GlassScriptPhysician profile
Danielle C Shockley
NPI 1396265021
$1,088.39
in general payments reported to CMS, 2019-2025
19 companies · $293 in 2025
The $293 reported for 2025 was more than what a typical Gerontology (Nurse Practitioner) provider received nationally (typical 2025 total: $180).
See the full distribution for Gerontology (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $396 · 2024: $400 · 2025: $293.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $692.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $692.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $239.80 | 2021 | |
| Travere Therapeutics, INC. | $163.70 | 2024-2025 | |
| Boston Scientific Corporation | $149.74 | 2021-2024 | Watchman Flx |
| Baxter Healthcare | $109.50 | 2024 | |
| Shield Therapeutics INC | $83.00 | 2024-2025 | |
| Calliditas Therapeutics US INC. | $63.15 | 2025 | Tarpeyo |
| Bayer Healthcare Pharmaceuticals INC. | $38.31 | 2025 | |
| Abbott Laboratories | $27.16 | 2024 | Jot Dx, Aveir |
| Ardelyx, INC. | $25.81 | 2024 | Ibsrela |
| Glaxosmithkline, LLC. | $25.42 | 2025 | Benlysta |
| Xeris Pharmaceuticals, INC. | $22.57 | 2025 | Gvoke Hypopen |
| Regeneron Healthcare Solutions, INC. | $22.11 | 2024 | Evkeeza |
| Fresenius USA Marketing, INC. | $19.94 | 2024 | Nxstage System One |
| Ibsa Pharma INC. | $19.44 | 2025 | Tirosint, Licart, Flector |
| Akebia Therapeutics INC | $18.64 | 2025 | Vafseo |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $16.93 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $16.36 | 2024 | Jardiance |
| Novo Nordisk INC | $13.91 | 2025 | Ozempic |
| Astrazeneca Pharmaceuticals LP | $12.90 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Danielle Shockley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.